CALGARY – SemBioSys Genetics Inc. (TSX:SBS) stock plunged 70 per cent on Wednesday after it announced a voluntary delisting from the Toronto Stock Exchange and said the company may be wound up if it can’t find a buyer or financial backer.
The development-stage company, which has proprietary technology for creating high-value proteins, said Wednesday it has laid off most of its staff and contractors and it’s looking for a strategic deal or a windup of the company.
Get weekly money news
SemBioSys signed a strategic partnership with Tianjin Tasly Pharmaceuticals Co. Ltd. and Tasly Pharmaceuticals Inc. in October but SemBioSys said Wednesday there hasn’t been any financial benefit to it since then.
The Calgary-based company says it hasn’t transferred any intellectual property to the joint venture to date.
- Alberta tweaks carbon capture incentive program to allow grants during construction
- ‘Cash is king’: Why money is a popular holiday present for many Canadians
- Rancher says Alberta well cleanup fund a positive step — but litany of concerns remain
- What makes the Anthropic IPO so significant, and what is the ‘god share’?
Its shares closed Tuesday at 6.5 cents, giving SemBioSys a total market value of less than $3.4 million at that time. But the stock plunged when the Toronto Stock Exchange, cutting the market value by about 70 per cent.
SemBioSys shares were down 4.5 cents to two cents in early trading.
Comments
Want to discuss? Please read our Commenting Policy first.